Benign prostatic hyperplasia and prostate cancer are androgendependent diseases that afflict a large percentage of males over the age of fifty, and are usually treated by surgery. 1 Dihydrotestosterone, a 5-α-reductase metabolite of testosterone, has been implicated as a causative factor in the progression of these diseases. 2 It has also been determined that dihydrotestosterone interacts more efficiently with the androgen receptors than testosterone. This fact indicates that the logical step in treating these diseases should be an inhibition of the 5-αreductase enzyme, 3 or blockage of dihydrotestosterone-receptor complex formation. 4, 5 In this paper, we describe the synthesis and X-ray structure determination of a new antiandrogen, 3β-acetoxy-4,16pregnadiene-6,20-dione 4. This compound was prepared from the commercially available 3β-acetoxypregna-5,16-diene-20one 1 described in Scheme 1.
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X-ray data for crystals of the title compound were collected by graphite-monochromatized Mo Kα radiation at 293 K. No absorption correction was applied. The structure was solved by direct methods and refined by full-matrix least-squares with anisotropic temperature factors for the non-hydrogen atoms. O4 shows two atomic positions with occupancy factors for O4A and O4B of 0.50, respectively. The positions of all H atoms were calculated geometrically and a riding model was used in their refinement, with C-H distances in the range of 0.85 -0.98 Å and Uiso(H) = 1.2Ueq (C). The software used to prepare the material for publication was PARST97. 6 Table 1 summarizes the crystal and experimental data. The molecular structure is shown in Fig. 1 . The bond angles, the final atomic parameters for the hydrogen atoms, anisotropic thermal parameters for nonhydrogen atoms, and the observed and calculated structure factors may be obtained from the first author.
The molecule consists of three six-membered rings and one five-membered ring, all trans fused. For the puckeringparameters values (φ2, θ2 and Q), 7 and distorted chair ( 1 C4) conformations, respectively. Ring D occurs in a distorted envelope conformation. The bond lengths and angles are normal. The absolute configuration is inferred from the known stereochemistry of 3β-acetoxypregna-5,16diene-20-one 1. Compound 1 is commercially available. The stereochemistry of the title compound is as follows: C8-βH is trans to C9-αH; C9-αH is trans to C10-βCH3; C13-βCH3 is trans to C14-αH.
There are three intramolecular C-H···O interactions [C3···O4A, C3···O4B, C4···O2 2.714(7), 2.634(6), 2.852(4)Å; H3···O4A, H3···O4B, H4···O2, 2.244(6), 2.332(5), 2.583(2)Å; C3-H3···O4A, C3-H3···O4B, C4-H4···O2, 108.2(3), 96.8(2), 97.2(2)˚]. In addition, there are three intermolecular C-H···O interactions<3.4 Å: C21···O4B (x + 1/2, -y + 1/2, -z + 2); C16···O4A, C16···O4B (x -1, y, z), 3.345(7), 3.275(7) and 3.385(6)Å, respectively. Apart from the C···O intra-and intermolecular interactions, the molecules in the crystal are packed at normal van der Waals distances. Table 3 Bond distances (Å)
